Although several NIRS studies (60, 61) have also investigated the effects of rTMS on the MDD patients and described a modulation of the blood oxygenation response over the PFC that was built up during the course of rTMS treatment in depression, these studies measured the oxy-Hb response during TMS, not during a cognitive task. Here, GSTM1 is linked to depressive symptom measurement.